Bone marrow cell transplantation in clinical perspective
- PMID: 15698828
- DOI: 10.1016/j.yjmcc.2004.12.005
Bone marrow cell transplantation in clinical perspective
Abstract
The deficit in left ventricular performance in an ischemically damaged heart is characterized by depletion of functioning cardiomyocytes. The problem is accentuated by the inadequate intrinsic repair mechanism of the heart. Recent progress in regenerative medicine has paved way for an outside intervention to support the limited on-going reparative process in the heart through transplantation of cells with myogenic and/or angiogenic potential. The functional plasticity of bone marrow derived stem cells has been exploited for cardiac repair. The early experiences in proof-of-concept animal studies and phase-1 clinical trials have been encouraging and suggest the safety, feasibility and potential of this approach. We critically review the literature in depth to elucidate the progress in this field together with discussion of the problems and controversies that need to be addressed in order to fully exploit the potential of bone marrow stem cell transplantation with clinical relevance.
Similar articles
-
Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells.Semin Thorac Cardiovasc Surg. 2005 Winter;17(4):348-60. doi: 10.1053/j.semtcvs.2005.09.004. Semin Thorac Cardiovasc Surg. 2005. PMID: 16428043 Review.
-
Neovascularization and cardiac repair by bone marrow-derived stem cells.Handb Exp Pharmacol. 2006;(174):283-98. Handb Exp Pharmacol. 2006. PMID: 16370332 Review.
-
Haematopoietic stem cells and repair of the ischaemic heart.Clin Sci (Lond). 2005 Dec;109(6):483-92. doi: 10.1042/CS20050087. Clin Sci (Lond). 2005. PMID: 16287425 Review.
-
Bone marrow as a source of stem cells and germ cells? Perspectives for transplantation.Cell Tissue Res. 2007 Apr;328(1):1-5. doi: 10.1007/s00441-006-0361-7. Epub 2007 Jan 10. Cell Tissue Res. 2007. PMID: 17216191 Review.
-
Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells.Handb Exp Pharmacol. 2007;(180):117-65. doi: 10.1007/978-3-540-68976-8_6. Handb Exp Pharmacol. 2007. PMID: 17554507 Review.
Cited by
-
TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium.Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1442-50. doi: 10.1152/ajpheart.00917.2010. Epub 2011 Feb 4. Am J Physiol Heart Circ Physiol. 2011. PMID: 21297031 Free PMC article.
-
Present status and perspectives of stem cell-based therapies for gastrointestinal diseases.Stem Cell Rev Rep. 2009 Sep;5(3):278-82. doi: 10.1007/s12015-009-9070-4. Epub 2009 May 27. Stem Cell Rev Rep. 2009. PMID: 19590987 Review.
-
TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1124-30. doi: 10.1152/ajpregu.90508.2008. Epub 2008 Aug 6. Am J Physiol Regul Integr Comp Physiol. 2008. PMID: 18685063 Free PMC article.
-
Embryonic stem cells in cardiac repair and regeneration.Antioxid Redox Signal. 2009 Aug;11(8):1857-63. doi: 10.1089/ars.2009.2491. Antioxid Redox Signal. 2009. PMID: 19203218 Free PMC article. Review.
-
Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium.Mol Pharm. 2011 Oct 3;8(5):1573-81. doi: 10.1021/mp2001704. Epub 2011 May 24. Mol Pharm. 2011. PMID: 21542647 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical